Bayer Aktiengesellschaft (BAYRY)
OTCMKTS
· Delayed Price · Currency is USD
5.14
+0.05 (0.98%)
Nov 22, 2024, 3:39 PM EST
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 9.97B EUR in the quarter ending September 30, 2024, a decrease of -3.62%. This brings the company's revenue in the last twelve months to 46.74B, down -2.17% year-over-year. In the year 2023, Bayer Aktiengesellschaft had annual revenue of 47.64B, down -6.11%.
Revenue (ttm)
46.74B EUR
Revenue Growth
-2.17%
P/S Ratio
n/a
Revenue / Employee
482.19K EUR
Employees
96,931
Market Cap
20.22B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | 43.55B | 6.80B | 18.52% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
Bayer Aktiengesellschaft News
- 7 hours ago - Bayer's (BAYRY) Nubeqa sNDA for Prostate Cancer Accepted by FDA - GuruFocus
- 1 day ago - Bayer Announces ‘Project Enhanced S3' to Enable Companies to Realize Additional Sustainability Value from Carbon Removal Projects - Business Wire
- 3 days ago - Cytokinetics and Bayer partner to develop for aficamten in Japan - Seeking Alpha
- 3 days ago - Bayer (BAYRY) and Cytokinetics (CYTK) Collaborate on Japanese HCM Therapy - GuruFocus
- 3 days ago - Cytokinetics and Bayer Partner to Expand Aficamten's Reach in Japan - GuruFocus
- 3 days ago - Bayer acquires rights to Cytokinetics' heart drug in Japan - Reuters
- 7 days ago - Bayer Faces Investor Pressure to Accelerate Turnaround Amid Record Lows - CEOWORLD magazine
- 7 days ago - Bayer’s Worst Week in a Year Puts Scale of CEO Task Into Context - BNN Bloomberg